The gut microbiota shapes systemic immunity not only by triggering NLRP3 inflammasome activation but also by releasing metabolites that directly program T‑cell fate. I hypothesize that succinate, a TCA‑cycle intermediate enriched in dysbiotic microbiomes, acts as an upstream signal that amplifies NLRP3 signaling in innate immune cells and, through IL‑1β/IL‑18 release, stabilizes HIF‑1α in CD8⁺ T cells. HIF‑1α then transcriptionally programs the exhaustion circuit, increasing PD‑1, TIM-3 and TIGIT expression while suppressing mitochondrial oxidative phosphorylation. This creates a feed‑forward loop where exhausted T cells produce less IFN‑γ, further weakening mucosal barrier repair and perpetuating gut‑derived inflammation.

Key predictions: (1) Mice colonized with succinate‑producing strains (e.g., certain Bacteroides spp.) will show higher serum succinate, elevated NLRP3 caspase‑1 activity in lamina propria DCs, and increased HIF‑1α signaling in splenic and cerebral CD8⁺ T cells compared with germ‑free controls. (2) Genetic deletion of SUCNR1 (the succinate receptor) in DCs will blunt NLRP3 activation and reduce IL‑1β/IL‑18 despite dysbiosis. (3) Pharmacologic HIF‑1α inhibition (e.g., with PX‑478) will rescue T‑cell effector function and lower exhaustion marker expression even when succinate levels remain high.

To test this, we will run four experimental groups: (a) germ‑free mice + vehicle, (b) germ‑free mice + succinate‑producing consortium, (c) same as (b) but with DC‑specific SUCNR1 KO, and (d) same as (b) treated with HIF‑1α inhibitor. Readouts will include colonic barrier integrity (FITC‑dextran assay), serum succinate (LC‑MS), NLRP3 activity (Western for cleaved caspase‑1, IL‑1β ELISA), and T‑cell phenotypes (flow cytometry for PD-1, TIM-3, TIGIT, mitochondrial mass, and Seahorse OCR/ECAR). If succinate‑driven NLRP3 activation is necessary and sufficient for HIF‑1α‑dependent T‑cell exhaustion, groups (c) and (d) should show exhaustion markers comparable to germ‑free controls despite microbial succinate overload.

This hypothesis extends the gut→NLRP3→inflammation axis by linking a specific microbial metabolite to a transcriptional program that directly imposes T‑cell dysfunction, offering a testable mechanistic bridge between intestinal dysbiosis and the immunosenescence hallmark of aging. Failure to observe the predicted changes would falsify the claim that succinate‑SUCNR1‑NLRP3‑HIF‑1α signaling is a causal route to T‑cell exhaustion, redirecting focus to other gut‑derived signals.